Gain-of-function mutations in the ALS8 causative gene VAPB have detrimental effects on neurons and muscles

Biology Open

Volumn 3, Issue 1, 2014, Pages 59-71

  Sanhueza, Mario ^a   Zechini, Luigi ^a   Gillespie, Trudy ^a   Pennetta, Giuseppa ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

ALS; Drosophila; Genetics; Neurodegeneration; VAPB

Indexed keywords

EID: 84901193085     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20137070     Document Type: Article

References (67)

1. Aliaga, L., Lai, C., Yu, J., Chub, N., Shim, H., Sun, L., Xie, C., Yang, W. J., Lin, X., O?Donovan, M. J. et al. (2013). Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. Hum. Mol. Genet. 22, 4293-4305.
2. Amarilio, R., Ramachandran, S., Sabanay, H. and Lev, S. (2005). Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J. Biol. Chem. 280, 5934-5944.
3. Anagnostou, G., Akbar, M. T., Paul, P., Angelinetta, C., Steiner, T. J. and de Belleroche, J. (2010). Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging 31, 969-985.
4. Bischof, J., Maeda, R. K., Hediger, M., Karch, F. and Basler, K. (2007). An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc. Natl. Acad. Sci. USA 104, 3312-3317.
5. Blauw, H. M., Barnes, C. P., van Vught, P. W., van Rheenen, W., Verheul, M., Cuppen, E., Veldink, J. H. and van den Berg, L. H. (2012). SMN1 gene duplications are associated with sporadic ALS. Neurology 78, 776-780.
6. Brand, A. H. and Perrimon, N. (1993). Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415.
7. Budnik, V., Koh, Y. H., Guan, B., Hartmann, B., Hough, C., Woods, D. and Gorczyca, M. (1996). Regulation of synapse structure and function by the Drosophila tumor suppressor gene dlg. Neuron 17, 627-640.
8. Bürglen, L., Spiegel, R., Ignatius, J., Cobben, J. M., Landrieu, P., Lefebvre, S., Munnich, A. and Melki, J. (1995). SMN gene deletion in variant of infantile spinal muscular atrophy. Lancet 346, 316-317.
9. Chai, A., Withers, J., Koh, Y. H., Parry, K., Bao, H., Zhang, B., Budnik, V. and Pennetta, G. (2008). hVAPB, the causative gene of a heterogeneous group of motor neuron diseases in humans, is functionally interchangeable with its Drosophila homologue DVAP-33A at the neuromuscular junction. Hum. Mol. Genet. 17, 266-280.
10. Chan, H. Y. and Bonini, N. M. (2000). Drosophila models of human neurodegenerative disease. Cell Death Differ. 7, 1075-1080.
11. Chen, H. J., Anagnostou, G., Chai, A., Withers, J., Morris, A., Adhikaree, J., Pennetta, G. and de Belleroche, J. S. (2010). Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J. Biol. Chem. 285, 40266-40281.
12. Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A. and Guo, M. (2006). Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162-1166.
13. Eisele, Y. S. (2013). From soluble ab to progressive ab aggregation: could prion-like templated misfolding play a role? Brain Pathol. 23, 333-341.
14. Forrest, S., Chai, A., Sanhueza, M., Marescotti, M., Parry, K., Georgiev, A., Sahota, V., Mendez-Castro, R. and Pennetta, G. (2013). Increased levels of phosphoinositides cause neurodegeneration in a Drosophila model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 2689-2704.
15. Franco, B., Bogdanik, L., Bobinnec, Y., Debec, A., Bockaert, J., Parmentier, M. L. and Grau, Y. (2004). Shaggy, the homolog of glycogen synthase kinase 3, controls neuromuscular junction growth in Drosophila. J. Neurosci. 24, 6573-6577.
16. Funke, A. D., Esser, M., Krü ttgen, A., Weis, J., Mitne-Neto, M., Lazar, M., Nishimura, A. L., Sperfeld, A. D., Trillenberg, P., Senderek, J. et al. (2010). The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case. Clin. Genet. 77, 302-303.
17. Gkogkas, C., Middleton, S., Kremer, A. M., Wardrope, C., Hannah, M., Gillingwater, T. H. and Skehel, P. (2008). VAPB interacts with and modulates the activity of ATF6. Hum. Mol. Genet. 17, 1517-1526.
18. Halder, G., Callaerts, P., Flister, S., Walldorf, U., Kloter, U. and Gehring, W. J. (1998). Eyeless initiates the expression of both sine oculis and eyes absent during Drosophila compound eye development. Development 125, 2181-2191.
19. Han, S. M., Tsuda, H., Yang, Y., Vibbert, J., Cottee, P., Lee, S.-J., Winek, J., Haueter, C., Bellen, H. J. and Miller, M. A. (2012). Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors. Dev. Cell 22, 348-362.
20. Hauck, B., Gehring, W. J. and Walldorf, U. (1999). Functional analysis of an eye specific enhancer of the eyeless gene in Drosophila. Proc. Natl. Acad. Sci. USA 96, 564-569.
21. Hummel, T., Krukkert, K., Roos, J., Davis, G. and Klämbt, C. (2000). Drosophila Futsch/22C10 is a MAP1B-like protein required for dendritic and axonal development. Neuron 26, 357-370.
22. Ingre, C., Pinto, S., Birve, A., Press, R., Danielsson, O., de Carvalho, M., GuMmundsson, G. and Andersen, P. M. (2013). No association between VAPB mutations and familial or sporadic ALS in Sweden, Portugal and Iceland. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 620-627.
23. Kabashi, E., El Oussini, H., Bercier, V., Gros-Louis, F., Valdmanis, P. N., McDearmid, J., Mejier, I. A., Dion, P. A., Dupre, N., Hollinger, D. et al. (2013). Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 2350-2360.
24. Kaiser, S. E., Brickner, J. H., Reilein, A. R., Fenn, T. D., Walter, P. and Brunger, A. T. (2005). Structural basis of FFAT motif-mediated ER targeting. Structure 13, 1035-1045.
25. Kamimura, K., Ueno, K., Nakagawa, J., Hamada, R., Saitoe, M. and Maeda, N. (2013). Perlecan regulates bidirectional Wnt signaling at the Drosophila neuromuscular junction. J. Cell Biol. 200, 219-233.
26. Kanekura, K., Nishimoto, I., Aiso, S. and Matsuoka, M. (2006). Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J. Biol. Chem. 281, 30223-30233.
27. Kontopoulos, E., Parvin, J. D. and Feany, M. B. (2006). a-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum. Mol. Genet. 15, 3012-3023.
28. Kuijpers, M., Yu, K. L., Teuling, E., Akhmanova, A., Jaarsma, D. and Hoogenraad, C. C. (2013a). The ALS8 protein VAPB interacts with the ER-Golgi recycling protein YIF1A and regulates membrane delivery into dendrites. EMBO J. 32, 2056-2072.
29. Kuijpers, M., van Dis, V., Haasdijk, E. D., Harterink, M., Vocking, K., Post, J. A., Scheper, W., Hoogenraad, C. C. and Jaarsma, D. (2013b). Amyotrophic lateral sclerosis (ALS)-associated VAPB-P56S inclusions represent an ER quality control compartment. Acta Neuropathol. Commun. 1, 24.
30. Landers, J. E., Leclerc, A. L., Shi, L., Virkud, A., Cho, T., Maxwell, M. M., Henry, A. F., Polak, M., Glass, J. D., Kwiatkowski, T. J. et al. (2008). New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. Neurology 70, 1179-1185.
31. Langou, K., Moumen, A., Pellegrino, C., Aebischer, J., Medina, I., Aebischer, P. and Raoul, C. (2010). AAV-mediated expression of wild-type and ALS-linked mutant VAPB selectively triggers death of motoneurons through a Ca2+-dependent ER-associated pathway. J. Neurochem. 114, 795-809.
32. Lev, S., Ben Halevy, D., Peretti, D. and Dahan, N. (2008). The VAP protein family: from cellular functions to motor neuron disease. Trends Cell Biol. 18, 282-290.
33. Lin, D. M. and Goodman, C. S. (1994). Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron 13, 507-523.
34. Liu, G.-H., Qu, J., Suzuki, K., Nivet, E., Li, M., Montserrat, N., Yi, F., Xu, X., Ruiz, S., Zhang, W. et al. (2012). Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature 491, 603-607.
35. Millecamps, S., Salachas, F., Cazeneuve, C., Gordon, P., Bricka, B., Camuzat, A., Guillot-Noël, L., Russaouen, O., Bruneteau, G., Pradat, P. F. et al. (2010). SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J. Med. Genet. 47, 554-560.
36. Mitne-Neto, M., Machado-Costa, M., Marchetto, M. C. N., Bengtson, M. H., Joazeiro, C. A., Tsuda, H., Bellen, H. J., Silva, H. C. A., Oliveira, A. S. B., Lazar, M. et al. (2011). Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum. Mol. Genet. 20, 3642-3652.
37. Mórotz, G. M., De Vos, K. J., Vagnoni, A., Ackerley, S., Shaw, C. E. and Miller, C. C. J. (2012). Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum. Mol. Genet. 21, 1979-1988.
38. Nishimura, Y., Hayashi, M., Inada, H. and Tanaka, T. (1999). Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane proteinassociated (VAMP-associated) proteins. Biochem. Biophys. Res. Commun. 254, 21-26.
39. Nishimura, A. L., Mitne-Neto, M., Silva, H. C., Richieri-Costa, A., Middleton, S., Cascio, D., Kok, F., Oliveira, J. R., Gillingwater, T., Webb, J. et al. (2004). A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75, 822-831.
40. Pasinelli, P. and Brown, R. H. (2006). Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710-723.
41. Pennetta, G., Hiesinger, P. R., Fabian-Fine, R., Meinertzhagen, I. A. and Bellen, H. J. (2002). Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron 35, 291-306.
42. Peretti, D., Dahan, N., Shimoni, E., Hirschberg, K. and Lev, S. (2008). Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. Mol. Biol. Cell 19, 3871-3884.
43. Polymenidou, M. and Cleveland, D. W. (2012). Prion-like spread of protein aggregates in neurodegeneration. J. Exp. Med. 209, 889-893.
44. Puckelwartz, M. J., Kessler, E., Zhang, Y., Hodzic, D., Randles, K. N., Morris, G., Earley, J. U., Hadhazy, M., Holaska, J. M., Mewborn, S. K. et al. (2009). Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like phenotype in mice. Hum. Mol. Genet. 18, 607-620.
45. Puckelwartz, M. J., Kessler, E. J., Kim, G., Dewitt, M. M., Zhang, Y., Earley, J. U., Depreux, F. F. S., Holaska, J., Mewborn, S. K., Pytel, P. et al. (2010). Nesprin-1 mutations in human and murine cardiomyopathy. J. Mol. Cell. Cardiol. 48, 600-608.
46. Qiu, L., Qiao, T., Beers, M., Tan, W., Wang, H., Yang, B. and Xu, Z. (2013). Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice. Mol. Neurodegener. 8, 1-16.
47. Ratnaparkhi, A., Lawless, G. M., Schweizer, F. E., Golshani, P. and Jackson, G. R. (2008). A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS ONE 3, e2334.
48. Rezával, C., Werbajh, S. and Ceriani, M. F. (2007). Neuronal death in Drosophila triggered by GAL4 accumulation. Eur. J. Neurosci. 25, 683-694.
49. Robberecht, W. and Philips, T. (2013). The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 14, 248-264.
50. Roos, J., Hummel, T., Ng, N., Klämbt, C. and Davis, G. W. (2000). Drosophila Futsch regulates synaptic microtubule organization and is necessary for synaptic growth. Neuron 26, 371-382.
51. Skehel, P. A., Fabian-Fine, R. and Kandel, E. R. (2000). Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc. Natl. Acad. Sci. USA 97, 1101-1106.
52. Soussan, L., Burakov, D., Daniels, M. P., Toister-Achituv, M., Porat, A., Yarden, Y. and Elazar, Z. (1999). ERG30, a VAP-33-related protein, functions in protein transport mediated by COPI vesicles. J. Cell Biol. 146, 301-312.
53. Suzuki, H. and Matsuoka, M. (2011). Amyotrophic lateral sclerosis-linked mutant VAPB enhances TDP-43-induced motor neuronal toxicity. J. Neurochem. 119, 1099-1107.
54. Suzuki, H., Kanekura, K., Levine, T. P., Kohno, K., Olkkonen, V. M., Aiso, S. and Matsuoka, M. (2009). ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J. Neurochem. 108, 973-985.
55. Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M. O., Akhmanova, A., Jaarsma, D. and Hoogenraad, C. C. (2007). Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J. Neurosci. 27, 9801-9815.
56. Torres-Benito, L., Ruiz, R. and Tabares, L. (2012). Synaptic defects in spinal muscular atrophy animal models. Dev. Neurobiol. 72, 126-133.
57. Torroja, L., Packard, M., Gorczyca, M., White, K. and Budnik, V. (1999). The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J. Neurosci. 19, 7793-7803.
58. Tsuda, H., Han, S. M., Yang, Y., Tong, C., Lin, Y. Q., Mohan, K., Haueter, C., Zoghbi, A., Harati, Y., Kwan, J. et al. (2008). The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell 133, 963-977.
59. Tsujikawa, M., Omori, Y., Biyanwila, J. and Malicki, J. (2007). Mechanism of positioning the cell nucleus in vertebrate photoreceptors. Proc. Natl. Acad. Sci. USA 104, 14819-14824.
60. Tudor, E. L., Galtrey, C. M., Perkinton, M. S., Lau, K. F., De Vos, K. J., Mitchell, J. C., Ackerley, S., Hortobágyi, T., Vámos, E., Leigh, P. N. et al. (2010). Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience 167, 774-785.
61. Vabulas, R. M., Raychaudhuri, S., Hayer-Hartl, M. and Hartl, F. U. (2010). Protein folding in the cytoplasm and the heat shock response. Cold Spring Harb. Perspect. Biol. 2, a004390-a004390.
62. van Blitterswijk, M., van Es, M. A., Koppers, M., van Rheenen, W., Medic, J., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., Veldink, J. H. and van den Berg, L. H. (2012). VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient. Neurobiol. of Aging 33, 2950e1-2950e4.
63. Wang, H. F., Shih, Y. T., Chen, C. Y., Chao, H. W., Lee, M. J. and Hsueh, Y. P. (2011). Valosin-containing protein and neurofibromin interact to regulate dendritic spine density. J. Clin. Invest. 121, 4820-4837.
64. Worman, H. J., Ostlund, C. and Wang, Y. (2010). Diseases of the nuclear envelope. Cold Spring Harb. Perspect. Biol. 2, a000760.
65. Yang, Z., Huh, S. U., Drennan, J. M., Kathuria, H., Martinez, J. S., Tsuda, H., Hall, M. C. and Clemens, J. C. (2012). Drosophila Vap-33 is required for axonal localization of Dscam isoforms. J. Neurosci. 32, 17241-17250.
66. Yoo, Y. E. and Ko, C. P. (2011). Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 231, 147-159.
67. Zhang, Y. Q., Bailey, A. M., Matthies, H. J., Renden, R. B., Smith, M. A., Speese, S. D., Rubin, G. M. and Broadie, K. (2001). Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107, 591-603.